Abstract:
This invention provides methods of using labeled primers or probes for nucleic acid target detection and to detect the identity or presence of a nucleotide at certain positions in nucleic acid sequences with single molecule sensitivity using nanopore detection, and sets of oligonucleotide primers for use in such methods, as well as methods of quantitative PCR coupled with nanopore detection.
Abstract:
Novel methods of ChlP-seq are disclosed herein. These methods of ChlP-seq employ carrier DNA to prevent loss of DNA samples. The greater DNA yields achieved by this invention permit ChlP-seq of a small number of cells, permitting epigenetic analysis of primary cells of limited quantity.
Abstract:
Novel methods of ChlP-seq are disclosed herein. These methods of ChlP-seq employ carrier DNA to prevent loss of DNA samples. The greater DNA yields achieved by this invention permit ChlP-seq of a small number of cells, permitting epigenetic analysis of primary cells of limited quantity.
Abstract:
An embodiment of a method for correcting an error associated with phasic synchrony of sequence data generated from a population of template molecules is described that comprises the steps of detecting signals generated in response to nucleotide species introduced during a sequencing reaction; generating an observed value for the signal detected from each of the nucleotide species; defining positive incorporation values and negative incorporation values from the observed values using a carry forward value and an incomplete extension value; revising the carry forward value and the incomplete extension value using a noise value that is derived from observed values associated with the negative incorporation values; re- defining the positive incorporation values and the negative incorporation values using the revised carry forward value and the revised incomplete extension value; and repeating the steps of revising and re-defining until convergence of the positive incorporation values and the negative incorporation values.
Abstract:
This invention provides a process for sequencing nucleic acids using 3' modified deoxynucleotide analogues or 3' modified deoxyinosine triphosphate analogues, and 3' modified dideoxynucleotide analogues having a detectable marker attached thereto.
Abstract:
The invention provides a nucleotide or nucleoside having a base attached to a detectable label via a cleavable linker, characterised in that the cleavable linker contains a moiety selected from the group comprising : Formula (I) (wherein X is selected from the group comprising O, S, NH and NQ wherein Q is a C 1-10 substituted or unsubstituted alkyl group, Y is selected from the group comprising O, S, NH and N(allyl), T is hydrogen or a C 1-10 substituted or unsubstituted alkyl group and * indicates where the moiety is connected to the remainder of the nucleotide or nucleoside).
Abstract:
Methods for the simultaneous sequencing of multiple nucleic acid molecules are provided. Preferred methods include simultaneous single-direction sequencing of multiple genes or forward and reverse sequencing from a single gene, within a single reaction vessel. Additional methods of the invention include combined amplification and sequencing of nucleic acids, from a variety of sources, within a single reaction and wherein nucleic acid products also can be simultaneously analyzed, and where the reaction can be either bidirectional or long unidirectional. Additional methods encompass combined amplification and sequencing of multiple nucleic acid molecules simultaneously.